Protein Profiling and Imaging by MALDI Mass Spectrometry Distinguishes Sarcoma Subtypes and Tumor Margins

Search
Help
FACES


It is quite common for surgical pathologists to microscopically examine tumors that are very difficult to differentially diagnose. A correct diagnosis is critical as it dictates patient treatment and extent of surgical resection. We employ tissue profiling to survey the proteome of tumors to identify proteins that are specific to a tumor subclassification. Shown is a “zoomed-in” spectrum of two tumors that are histologically challenging to differentially diagnose. Several proteins are specific to each subtype and we are identifying these and other subset-specific markers.
 
During and after surgical resection, it is imperative to demonstrate complete removal of tumor as remaining tumor cells will likely lead to recurrence. In fact, it is common that cancerous or precancerous cells are “left behind” because they are not recognized under normal light microscopy. Here, we show how imaging mass spectrometry detects cancer-related proteins beyond the “histologically normal” tissue. We are now proving that such proteins represent the “molecular margin” using traditional molecular biological experimentation.

Next Steps and Potential Projects:

  • Continue identifying and validating proteins that differentiate specific sarcoma subtypes
  • Amplify translocations beyond the histological margin to validate proteomic data

The VUMC Center for Bone Biology is a member of the VUMC Department of Medicine in the Division of Clinical Pharmacology.



Vanderbilt University is committed to principles of equal opportunity and affirmative action.

Webmasters: VCBB | VU | VUMC
Copyright © 2007, Vanderbilt University Medical Center